Passage Bio
PASG
PASG
99 hedge funds and large institutions have $278M invested in Passage Bio in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 22 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 101 → 99 (-2)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
34% less capital invested
Capital invested by funds: $419M → $278M (-$142M)
Holders
99
Holding in Top 10
3
Calls
$90K
Puts
$69K
Top Buyers
| 1 | +$10.1M | |
| 2 | +$9.64M | |
| 3 | +$3.34M | |
| 4 |
Morgan Stanley
New York
|
+$2.6M |
| 5 |
BlackRock
New York
|
+$2.37M |
Top Sellers
| 1 | -$24.4M | |
| 2 | -$19.2M | |
| 3 | -$5.37M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$1.4M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.38M |